TNF and Alzheimer disease: AD-MSC-Exo potently mitigated the in vitro OA model in chondrocytes stimulated with interleukin (IL)-1β, resulting in a significant reduction in the level of the inflammatory factors including tumor necrosis factor-α (TNF- α), NO, IL-6, and PGE2 [39].